We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Postpones Enforcement of Combination Product Rules, Outlines Requirements for Constituent Parts
FDA Postpones Enforcement of Combination Product Rules, Outlines Requirements for Constituent Parts
The FDA issued two guidances on postmarketing safety reporting for combination products, pushing back reporting requirements for certain combination products and clarifying reporting rules for their constituent parts.